tiprankstipranks
Trending News
More News >
Xilio Therapeutics (XLO)
NASDAQ:XLO
US Market
Advertisement

Xilio Therapeutics (XLO) Technical Analysis

Compare
193 Followers

Technical Sentiment

Overall Consensus
Neutral
10Bullish
3Neutral
8Bearish
Technical Analysis Consensus
Neutral
3Bullish
3Neutral
3Bearish
Moving Average Consensus
Buy
7Bullish
0Neutral
5Bearish
Xilio Therapeutics’s (XLO) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Xilio Therapeutics is a Sell.
Xilio Therapeutics’s (XLO) 20-Day exponential moving average is 0.69, while Xilio Therapeutics’s (XLO) share price is $0.7, making it a Buy.
Xilio Therapeutics’s (XLO) 50-Day exponential moving average is 0.71, while Xilio Therapeutics’s (XLO) share price is $0.7, making it a Sell.

Xilio Therapeutics (XLO) Pivot Points

Aug 16, 2025, 03:02 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.66
0.67
0.69
0.71
0.73
0.74
0.76
Fibonacci
0.67
0.69
0.70
0.71
0.72
0.73
0.74
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Xilio Therapeutics (XLO) Moving Averages

Aug 16, 2025, 03:02 AM
Period
Simple
Exponential
MA5
0.69Buy
0.69Buy
MA10
0.67Buy
0.69Buy
MA20
0.68Buy
0.69Buy
MA50
0.69Buy
0.71Sell
MA100
0.73Sell
0.74Sell
MA200
0.86Sell
0.81Sell
Xilio Therapeutics’s (XLO) 10-Day exponential moving average is 0.69, while Xilio Therapeutics’s (XLO) share price is $0.7, making it a Buy.
Xilio Therapeutics’s (XLO) 100-Day exponential moving average is 0.74, while Xilio Therapeutics’s (XLO) share price is $0.7, making it a Sell.
Xilio Therapeutics’s (XLO) stock price is $0.7 and Xilio Therapeutics’s (XLO) 50-day simple moving average is 0.69, creating a Buy signal.
Xilio Therapeutics’s (XLO) stock price is $0.7 and Xilio Therapeutics’s (XLO) 100-day simple moving average is 0.73, creating a Sell signal.
Xilio Therapeutics’s (XLO) stock price is $0.7 and Xilio Therapeutics’s (XLO) 200-day simple moving average is 0.86, creating a Sell signal.

Xilio Therapeutics (XLO) Technical Indicators

Aug 16, 2025, 03:02 AM
Name
Value
Implied Action
RSI (14)
52.80
Neutral
STOCH (9,6)
87.21
Sell
STOCHRSI (14)
82.29
Sell
MACD (12,26)
>-0.01
Sell
ADX (14)
11.51
Buy
Williams %R
-22.02
Buy
CCI (14)
47.11
Neutral
ATR (14)
0.04
-
Ultimate Oscillator
55.78
Neutral
ROC
0.00
Buy
Xilio Therapeutics’s (XLO) Relative Strength Index (RSI) is 52.80, creating a Neutral signal.
Xilio Therapeutics’s (XLO) Trend Strength Indicator (ADX) is 11.51, creating a Buy signal.
Xilio Therapeutics’s (XLO) Commodity Channel Index (CCI) is 47.11, creating a Neutral signal.

FAQ

Is XLO a Buy, Hold, or Sell?
Based on XLO’s technical indicators, XLO is a Hold.
    What is XLO’s RSI (14)?
    XLO’s RSI (14) is 52.80, which suggests XLO is a Neutral.
      What is XLO’s MACD?
      XLO’s MACD is >-0.01, which suggests XLO is a Sell.
        What is XLO’s 5-day moving average?
        XLO’s 5-day moving average is 0.69, which suggests XLO is a Buy.
          What is XLO’s 20-day moving average?
          XLO 20-day moving average is 0.68, which suggests XLO is a Buy.
            What is XLO’s 50-day moving average?
            XLO’s 50-day moving average is 0.69, which suggests XLO is a Buy.
              What is XLO’s 200-day moving average?
              XLO’s 200-day moving average is 0.86, which suggests XLO is a Sell.
                What is XLO’s Williams % R (14)?
                XLO’s Williams % R (14) is -22.02, which suggests XLO is a Buy.
                  What is XLO’s CCI (14)?
                  XLO’s CCI (14) is 47.11, which suggests XLO is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis